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A Bordetella bronchiseptica iron transport mutant was isolated following an enrichment procedure based on
streptonigrin resistance. The mutant displayed a growth defect on iron-restricted medium containing ferric
alcaligin as the sole iron source. In addition to the apparent inability to acquire iron from the siderophore, the
mutant failed to produce alcaligin as well as two known iron-regulated proteins, one of which is the AlcC
alcaligin biosynthesis protein. A 1.6-kb KpnI-PstI Bordetella pertussis DNA fragment mapping downstream of
the alcaligin biosynthesis genes alcABC restored both siderophore biosynthesis and expression of the iron-
regulated proteins to the mutant. Nucleotide sequencing of this complementing 1.6-kb region identified an open
reading frame predicted to encode a protein with strong similarity to members of the AraC family of tran-
scriptional regulators, for which we propose the gene designation alcR. Primer extension analysis localized an
iron-regulated transcription initiation site upstream of the alcR open reading frame and adjacent to sequences
homologous to the consensus Fur repressor binding site. The AlcR protein was produced by using an Esche-
richia coli expression system and visualized in electrophoretic gels. In-frame alcR deletion mutants of B.
pertussis and B. bronchiseptica were constructed, and the defined mutants exhibited the alcR mutant phenotype,
characterized by the inability to produce and transport alcaligin and express the two iron-repressed proteins.
The cloned alcR gene provided in trans restored these siderophore system activities to the mutants. Together,
these results indicate that AlcR is involved in the regulation of Bordetella alcaligin biosynthesis and transport
genes and is required for their full expression.
The ability of microorganisms to multiply depends on their
ability to acquire essential nutrients, among which iron is al-
most universally limiting in availability. The level of freely
available iron in the environment and the extracellular fluids of
mammalian hosts is many orders of magnitude below the iron
concentration of 4 3 1027 to 4 3 1026 M required for the
growth of most microorganisms (13, 56). Microbial strategies
for overcoming iron restriction can be grouped into two
classes: those mediated by siderophores (36, 42) and sidero-
phore-independent processes involving direct iron removal
from host molecules such as transferrin, lactoferrin, and heme-
containing compounds (38).
Upon iron starvation, bacteria may produce siderophores
and the cognate ferric siderophore transport machinery, as
well as express transport systems for heterologous microbial
siderophores and for siderophore-independent iron retrieval
from host compounds (36, 42). Strict regulation of iron assim-
ilation is necessary due to the formation of damaging oxygen
radical species catalyzed by excess intracellular iron. For most
bacteria studied to date, regulation of iron transport systems is
mediated primarily by the ferric uptake regulator protein, Fur,
which acts as a corepressor with ferrous iron under conditions
of iron abundance (4, 27). However, in addition to the negative
transcriptional regulator Fur, other transcriptional regulators
which positively regulate the expression of siderophore biosyn-
thesis and transport genes and genes involved in the uptake of
other iron compounds have been identified. The genes encod-
ing these positive regulators are themselves members of the
Fur regulon. The positively regulated iron transport systems
respond to the presence of the cognate siderophore or iron
compound and represent three mechanistic classes: (i) alter-
native sigma factors, such as the FecI regulator of Escherichia
coli ferric citrate transport genes (35); (ii) classical two-com-
ponent sensory transduction systems, as described for the
Pseudomonas aeruginosa PfeR-PfeS regulators of the ferric
enterobactin receptor PfeA (16); and (iii) AraC-like transcrip-
tional regulators, including the P. aeruginosa PchR pyochelin
biosynthesis and transport regulator protein (29, 30) and the
Yersinia pestis YbtA yersiniabactin receptor gene regulator
(21).
Both Bordetella pertussis and Bordetella bronchiseptica, the
causative agents of respiratory diseases in mammals (6, 44),
produce the macrocyclic dihydroxamate siderophore alcaligin
under iron-depleted growth conditions (12, 40). Alcaligin bio-
synthesis requires the action of an ornithine decarboxylase
encoded by the odc gene in a reaction yielding putrescine from
ornithine (10), as well as the alcABC gene products, which
have strong primary amino acid sequence similarity to the E.
coli IucD, IucB, and IucC aerobactin biosynthesis enzymes,
respectively (25, 33). On the basis of the similarities with the
Iuc enzymes, we have proposed that AlcA is an oxygenase
catalyzing the hydroxylation of putrescine, and AlcB is postu-
lated to function in an acylation step involving succinate. AlcC
is similar to the IucC aerobactin synthetase and may be in-
volved in one of the final steps in alcaligin biosynthesis. The
Bordetella alcABC genes are cotranscribed and comprise part
of an iron-regulated operon (32) with predicted Fur repressor
binding sites upstream of alcA (11, 25, 33). B. bronchiseptica fur
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mutants selected on the basis of manganese resistance were
deregulated for the production of alcaligin; the B. pertussis fur
gene restored iron repressibility of siderophore expression to
the mutants, confirming a role for the Fur repressor in regu-
lation of alcaligin biosynthesis (9).
In this paper, we report the identification of the Bordetella
alcR gene, encoding a protein predicted to be a member of the
AraC family of transcriptional regulators. Mutations in alcR
resulted in defects in both alcaligin biosynthesis and transport,
a pleiotropic phenotype which was restored to wild type by
genetic complementation using the alcR gene alone. The ac-
companying article by Pradel and colleagues (44a) describes an
independent study in which the Bordetella alcR gene was iden-
tified by a different experimental approach.
MATERIALS AND METHODS
Bacterial strains and culture conditions. E. coli DH5a (Bethesda Research
Laboratories, Gaithersburg, Md.), DH10B (Bethesda Research Laboratories),
and HB101 (7) were used as hosts for general DNA cloning procedures and as
donor strains in triparental matings. E. coli BL21(DE3) was used as the host for
bacteriophage T7 RNA polymerase-promoter protein expression studies (46,
53). Wild-type B. bronchiseptica B013N and alcaligin siderophore biosynthesis
mutant derivative BRM3 (odc) have been described previously (3, 10). The
spontaneous streptomycin-resistant derivative of wild-type B. pertussis UT25
(22), UT25Sm1, has been described elsewhere (33); isogenic B. pertussis mutant
PM-4, in which the 105-bp alcA promoter-operator chromosomal DNA region is
deleted (32), was used in primer extension experiments.
B. bronchiseptica and E. coli strains were cultured on Luria-Bertani (LB) agar
or in LB broth (39), and B. pertussis was cultured on Bordet-Gengou agar (6).
Bacteriophage T7 RNA polymerase-promoter protein expression experiments
with E. coli used M9 medium (39) supplemented with 0.2% glucose and 0.01%
L-amino acids (minus cysteine and methionine) or 0.01% Casamino Acids
(Difco, Detroit, Mich.). The defined culture medium for Bordetella strains was
Stainer-Scholte (SS) medium (51) modified as described previously (49); iron-
replete SS medium contained 36 mM FeSO4, and iron-depleted culture condi-
tions were achieved by deionization of the medium with Chelex100 (Bio-Rad,
Hercules, Calif.) as described elsewhere (3). Growth was monitored as optical
density with a spectrophotometer or a Klett-Summerson colorimeter equipped
with a no. 54 filter (Klett Manufacturing Co., Long Island City, N.Y.). The
following antibiotics were used at the indicated concentrations (in micrograms
per milliliter): kanamycin, 50; gentamicin, 10; tetracycline, 15; ampicillin, 100;
and streptomycin, 50.
Plasmids and genetic methods. Cosmid pCP1.11 was isolated from a B. per-
tussis UT25 chromosomal DNA library and has been described previously (33).
Plasmid pBRM6 carries an approximately 20-kb chromosomal alc DNA insert
fragment encompassing the mini-Tn5 lacZ1 marker from B. bronchiseptica alcC
mutant BRM6 (3). Plasmid pRK2013 (23) supplied transfer functions in matings.
Plasmid cloning vectors pGEM3Z (Promega, Madison, Wis.), pRK415 (34),
pBluescript SK1 and pBluescript KS1 (Stratagene, La Jolla, Calif.), and pET-3
(46) were used in the construction of recombinant plasmids. Suicide plasmid
vectors pSS1129 (52) and pEG7 and pEG18.3 (both kindly provided by Peggy
Cotter and Jeffrey F. Miller) were used in allelic-exchange procedures in the
construction of Bordetella mutants. Conjugal transfer of plasmids to Bordetella
strains was accomplished by methods described previously (10).
General genetic techniques were performed essentially as described previously
(47). DNA probes used in nucleic acid hybridizations were radiolabelled by the
random priming method (20) using the Random Primers DNA Labeling System
(Gibco BRL) and [a-32P]dCTP (ICN Radiochemicals, Irvine, Calif.). The nu-
cleotide sequence of alcR was determined on both strands by the dideoxy chain
termination method (48) using a Sequenase version 2.0 kit (United States Bio-
chemical Corp., Cleveland, Ohio) and double-stranded plasmid DNA templates
as described previously (19). Nucleotide sequencing was accomplished by using
a set of nested deletion derivatives of alc DNA generated with the Erase-a-base
system (Promega) and synthetic DNA oligonucleotide primers. Nucleotide se-
quence data management and analysis employed the EditSeq and Seqman mod-
ules of a demonstration version of the Lasergene sequence analysis software
system for the Macintosh PowerPC computer (DNASTAR, Inc., Madison, Wis.).
Database searches and data retrievals employed the BLAST (2) server provided
by the National Center for Biotechnology Information at the National Library of
Medicine. For protein database BLASTP searches, Bordetella DNA sequences
were translated in all possible reading frames and the amino acid sequences were
submitted to the National Center for Biotechnology Information for analysis
using the nonredundant database mandatory DATALIB search parameter. Mul-
tiple amino acid sequence alignments were performed by the Clustal method
(31) with the MegAlign module of the Lasergene sequence analysis software
system (DNASTAR, Inc.). Putative Bordetella Fur-binding sequences were iden-
tified by using the MegAlign software to locate DNA regions of at least 50%
identity over a 30-nucleotide search window with the dyad sequence 59-GATA
ATGATAATCATTATC-39, representing the proposed consensus E. coli Fur
binding site (14, 18).
Primer extension was performed as described previously (47), with 50 mg of
total RNA and 100 fmol of 32P-end-labelled oligonucleotide primer used per
reaction mixture. RNA was purified from B. pertussis strains grown in iron-
replete and iron-depleted SS media as described previously (33). RNA was
denatured at 85°C for 10 min and hybridized with radiolabelled antisense primer
overnight at 42°C. Extension reactions used 400 U of Moloney murine leukemia
virus reverse transcriptase (Bethesda Research Laboratories) at 37°C. The 35-
mer DNA oligonucleotide primer used to map the transcription initiation site
immediately upstream of alcR (59-GGTGGGGGGAGCGTCGGTTGTGTCAT
TGGCGTTGC-39) was antisense to nucleotides 148 to 182 of the sequence of
the 1.6-kb KpnI-PstI DNA fragment (see Fig. 3). The DNA primer was also used
to generate the accompanying DNA sequencing ladder from an alc plasmid
template.
Mutational analysis. (i) Isolation of B. bronchiseptica iron transport mutant
BRM10. A pool of B. bronchiseptica B013N cells randomly mutagenized with
mini-Tn5 lacZ1 (17) was cultured in iron-replete SS medium containing 100 mg
of the nonutilizable iron chelator ethylenediaminedi-[(o-hydroxyphenyl)acetic
acid] (EDDA) per ml at 37°C for 4 h to effect iron starvation status by restriction
of iron availability. The cultures were then provided with purified alcaligin
siderophore to a 20 mM concentration and streptonigrin (Sigma Chemical Co.,
St. Louis, Mo.) at concentrations ranging from 0 to 6 mg/ml in replicate cultures.
The cells were cultured for an additional 3 h and then spread onto LB agar
containing 50 mg of kanamycin per ml for growth of the survivor population
enriched for iron transport mutants. The resulting kanamycin-resistant colonies
were replica plated onto LB agar (iron replete), LB agar containing 30 mg of
EDDA per ml (LB-EDDA agar) (iron restricted), and LB-EDDA agar contain-
ing 20 mM alcaligin. One mutant, BRM10, which displayed a growth defect on
the two iron-restricted media compared with growth on iron-replete LB agar, a
potential iron transport mutant, was selected for further analysis.
(ii) Construction of defined Bordetella alcR deletion mutants. The 264-bp
NgoAIV fragment internal to the B. pertussis alcR gene was deleted by restriction
endonuclease cleavage followed by religation. The KpnI-PstI DNA subfragment
encompassing the mutated alcR gene was subcloned to the allelic-exchange
plasmid vector pSS1129, the resulting plasmid was mated to B. pertussis
UT25Sm1, and the mutation was transferred to the chromosome by homologous
recombination as described previously (52). Allelic exchange in B. pertussis mu-
tant PM10 was verified by Southern hybridization analysis.
For construction of a B. bronchiseptica alcR mutant, the 264-bp NgoAIV
fragment internal to the B. bronchiseptica alcR gene was deleted from the sub-
cloned 2.3-kb B. bronchiseptica EcoRI-PstI fragment of pBRM6 (3). From this
plasmid, a 2.0-kb EcoRI-HindIII fragment was subcloned to the allelic-exchange
plasmid vector pEG7, and the deletion mutation was introduced to the chromo-
some of B. bronchiseptica B013N by allelic exchange employing positive selection
on sucrose-containing medium as described previously (1). Presumptive mutants
were initially identified by in situ DNA hybridization analysis using the 264-bp
NgoAIV DNA fragment as the probe. Southern hybridization analysis confirmed
that the deletion had been transferred to the chromosome, resulting in B. bron-
chiseptica mutant BRM11.
Measurement of siderophore activity. The chrome azurol S (CAS) universal
siderophore detection assay (50) was used to monitor siderophore production by
Bordetella cells grown in SS medium by measurement of the decrease in absor-
bance of the CAS dye reaction at 630-nm wavelength relative to that of unin-
oculated culture medium. All siderophore assays were performed in triplicate.
CAS agar (50), modified as described previously (3), was also used for qualitative
assessment of B. bronchiseptica siderophore activity.
Alcaligin bioassays. Utilization of alcaligin for iron acquisition was determined
for B. bronchiseptica mutants in quantitative bioassays performed as described
previously (12), with the transport-proficient alcaligin biosynthesis mutant B.
bronchiseptica BRM3 used as a control indicator strain. Briefly, cells were cul-
tured on LB agar for 24 to 30 h, harvested, and suspended in LB to an A600 of
1.0, and a 100-ml volume of the suspension was added to 25 ml of molten
iron-restricted LB-EDDA agar (50°C) prior to being poured into a petri dish.
Wells were punched into the solidified agar, and 100-ml volumes of purified
alcaligin diluted serially in distilled water were added. The plates were incubated
at 37°C, and the diameters of bacterial growth zones surrounding the wells were
measured after 21 h.
Cell fractionation and SDS-PAGE. Bordetella cells harvested from iron-replete
and iron-depleted SS medium cultures were disrupted with a French pressure
cell (American Instrument Company, Silver Spring, Md.), and the soluble and
insoluble cell fractions were prepared as described previously (33). Protein sam-
ples were treated in sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) solubilization buffer at 100°C for 7 min, and the proteins were
resolved by SDS-PAGE on 10 or 12% polyacrylamide gels containing 0.5 M urea
as described previously (49). For analysis of total cellular proteins, Bordetella
cells were harvested from SS medium cultures by centrifugation and resuspended
directly in SDS-PAGE solubilization buffer. After electrophoresis, proteins were
visualized by Coomassie blue staining.
Expression of plasmid-encoded proteins. Plasmid-encoded proteins were con-
ditionally expressed in E. coli BL21(DE3) by using a bacteriophage T7 poly-
merase-promoter system (46, 53). Induction was achieved by addition of the lac
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inducer isopropyl-b-D-thiogalactopyranoside (IPTG) to bacterial cultures. Cells
were harvested by centrifugation and analyzed by SDS-PAGE on 12% polyacryl-
amide gels. Proteins were visualized by staining with Coomassie blue or intrinsic
radiolabelling using Tran35S-label (ICN Biochemicals, Inc.) and autoradiography
subsequent to SDS-PAGE.
Nucleotide sequence accession number. The GenBank accession number as-
signed to the B. pertussis UT25 alcR gene is AF018255.
RESULTS
Characterization of B. bronchiseptica mutant BRM10. A ran-
dom mutant pool of B. bronchiseptica cells carrying mini-Tn5
lacZ1 chromosomal insertions was exposed to streptonigrin to
enrich the population for cells defective in alcaligin-mediated
iron uptake. Mutant BRM10 displayed poor growth on low-
iron media, despite provision of exogenous alcaligin as a nor-
mally utilizable source of iron, suggesting that the mutant was
defective in alcaligin transport or utilization. Interestingly, fur-
ther characterization revealed that BRM10 was also defective
in alcaligin production.
B. pertussis recombinant cosmid pCP1.11, which carries a ca.
21-kb genetic region including the known alcABC alcaligin
biosynthesis operon, functionally restored siderophore bio-
synthesis to BRM10 (Fig. 1). Plasmid pRK4, a subclone of
pCP1.11 which carries the alcaligin biosynthesis genes alcABC
(33), did not complement BRM10, indicating that the defective
BRM10 gene was not one of the known alcaligin biosynthesis
genes. Further deletion analysis of pCP1.11 localized the
smallest complementing genetic region to a 1.6-kb KpnI-PstI
DNA fragment approximately 2 kb downstream of alcABC
(plasmid pP9KP).
BRM10 total cellular proteins and fractions from cells cul-
tured in high- and low-iron media were analyzed by SDS-
PAGE. Wild-type iron-starved B. bronchiseptica B013N cells
expressed the soluble AlcC protein with an apparent molecular
mass of 59 kDa (33), but mutant BRM10 carrying the plasmid
vector control pRK415 failed to produce detectable levels of
the protein (Fig. 2A). When pP9KP was provided to BRM10,
production of AlcC was restored. Plasmid pRK4 carrying
alcABC failed to restore expression of AlcC to BRM10, al-
though previous studies have shown that it restored both sid-
erophore biosynthesis and AlcC production to an alcC mutant
(33). An iron-repressed membrane protein with an approxi-
mate molecular mass of 79 kDa was observed in the insoluble
fraction prepared from the wild-type parent strain B013N, but
this protein was absent in mutant BRM10 samples (Fig. 2B).
Expression of this 79-kDa protein was also restored when
BRM10 was supplied with pP9KP, containing the B. pertussis
1.6-kb KpnI-PstI DNA fragment.
To map the location of the mini-Tn5 lacZ1 transposon mu-
tation in BRM10, relative to the B. pertussis 1.6-kb KpnI-PstI
DNA fragment which complemented the mutant phenotype,
the BRM10 transposon marker and flanking chromosomal
DNA sequences were cloned. Restriction endonuclease map-
ping of the cloned BRM10 chromosomal DNA fragment did
not reveal any similarity to the complementing B. pertussis
pCP1.11 cosmid or pP9KP DNA. Southern hybridizations
demonstrated no genetic homology between the BRM10 chro-
mosomal DNA region flanking the transposon and B. pertussis
pCP1.11 or pP9KP (data not shown). These results indicated
that the transposon was not located within the chromosomal
region of the mutant represented by either pCP1.11 or pP9KP,
although each plasmid was able to complement the BRM10
mutant phenotype. Nucleotide sequencing from the transpo-
son ends of the cloned BRM10 DNA did not reveal any se-
quence similarity with the 1.6-kb KpnI-PstI DNA fragment
from pCP1.11 or any known alc gene (data not shown). These
data suggested that the observed BRM10 siderophore-defec-
tive phenotype may not be related to the mini-Tn5 lacZ1 trans-
poson insertion and that the BRM10 phenotype may be attrib-
FIG. 1. Identification of the B. pertussis DNA region restoring alcaligin production to B. bronchiseptica mutant BRM10. Phenotypic complementation by B. pertussis
recombinant cosmid pCP1.11 and plasmid subclones was evaluated on CAS siderophore indicator agar. BRM10 carrying the designated plasmids was scored as follows:
1, siderophore activity was produced; 2, no siderophore activity was detected. The alcABC alcaligin biosynthesis genes and the newly identified alcR gene are indicated.
Abbreviations: B, BamHI; K, KpnI; P, PstI; S, SalI; Sm, SmaI; X, XhoI.
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utable to a spontaneous mutation selected during streptonigrin
enrichment affecting the activity encoded within the 1.6-kb
KpnI-PstI genetic region. To address this hypothesis, the ho-
mologous 1.6-kb KpnI-PstI DNA fragment was cloned from the
BRM10 chromosome, and its identity was verified by nucleo-
tide sequencing analysis. In contrast to the corresponding wild-
type region, when provided in trans and in multicopy to
BRM10, this BRM10-derived DNA fragment failed to com-
plement the alcaligin-defective phenotype of the mutant (data
not shown), providing suggestive evidence for a spontaneous
mutation in the putative BRM10 alc gene, supporting the hy-
pothesis that the transposon mutation is irrelevant to the iron
transport phenotype of BRM10.
Nucleotide sequence analysis of the 1.6-kb KpnI-PstI B. per-
tussis DNA fragment. Nucleotide sequence analysis of the
1.6-kb B. pertussis wild-type DNA fragment which comple-
mented the BRM10 mutant phenotype identified an open
reading frame, alcR, predicted to encode a protein with a
molecular mass of 36.4 kDa (Fig. 3). Two overlapping potential
Fur-binding DNA sequences which precede alcR, sharing 13
and 12 of the 19 bases of the consensus E. coli Fur-binding
sequence (14, 18), were identified. BLAST database searches
showed that the deduced AlcR protein exhibited remarkable
similarity to members of the AraC family of transcriptional
regulators (24) (Fig. 4). Similarity among the AraC family
members, including AlcR, is most pronounced at the carboxy
terminus (24). Most significantly, over the carboxy-terminal
82-amino-acid sequence, the deduced AlcR protein was 41%
identical to the carboxy-terminal region of PchR, the P. aerugi-
nosa AraC-like protein involved in regulation of pyochelin
biosynthesis and transport functions (29, 30). AlcR also exhib-
ited 32% identity over the same sequence interval with YbtA,
an AraC-like transcriptional regulator of pesticin/yersiniabac-
tin siderophore receptor expression in Y. pestis (21).
The 452-bp region downstream of alcR on the 1.6-kb KpnI-
PstI fragment contains a partial open reading frame predicted
to encode the amino terminus of a protein with high similarity
to members of the multidrug efflux system family (data not
shown) (43). The best similarity scores were with Pur8 (puro-
mycin resistance) of Streptomyces alboniger (now Streptomyces
anulatus) (GenBank accession no. X76855) (54) and E. coli
proteins Bcr (bicyclomycin resistance) (GenBank accession no.
X63703) (5) and EmrD (resistance to phenylmercury acetate
and carbonyl cyanide m-chlorophenylhydrazone) (Swiss-Prot
accession no. P31442) (41).
Determination of the transcription initiation site of alcR.
Other studies in this laboratory used a B. pertussis chromo-
somal mutant, PM-4, in which the alcA promoter-operator
region was deleted, to demonstrate cotranscription of alcABC
and to determine the 39 limit of the alc operon (32). Quanti-
tative RNA hybridization analyses using an alcR-specific probe
and RNA isolated from the wild type versus alcA promoter-
operator mutant PM-4 showed that alcR was transcribed pri-
marily from the upstream iron-regulated alcA promoter but
was also independently transcribed from a weaker secondary
iron-regulated promoter which retained its activity when the
alcA promoter-operator region was deleted. This secondary
promoter was analyzed in the present study by primer exten-
sion experiments, and the transcriptional initiation site was
determined.
Reverse transcription of mRNA from B. pertussis wild-type
strain UT25Sm1 and isogenic alcA promoter-operator deletion
mutant PM-4 using a synthetic primer corresponding to the
antisense of nucleotide positions 148 to 182 of the B. pertussis
DNA sequence (Fig. 3) revealed two extension products cor-
responding to transcription initiation sites at the C residue and
the adjacent T residue at positions 124 and 125, respectively
(Fig. 5). These iron-regulated transcripts from the wild-type
and mutant strains were mapped to the same initiation posi-
tions and were present in similar abundances, indicating that
an iron-regulated promoter, PalcR, resides immediately up-
stream of alcR and functions independently of the alcA pro-
moter. The alcR transcription initiation sites were located ad-
jacent to the putative Fur repressor binding site in a spatial
organization remarkably similar to that of the alcA promoter-
operator region (33). The RNA samples from wild-type cells
also yielded several longer iron-regulated extension products
presumably derived from reverse transcription of mRNA spe-
cies originating at the alcA promoter which were absent in
samples from mutant PM-4.
Inspection of the region upstream of the alcR transcription
start site revealed sequences with similarity to E. coli s70 pro-
moter determinants (28). The transcription initiation site is
optimally spaced 6 nucleotides from the hexameric sequence
59-TATCAT-39 (positions 212 to 27 with respect to the tran-
scription start site 11), which shares five of six of the most
highly conserved nucleotides with the E. coli s70 210 consen-
sus sequence TATAAT, including the invariant T (28) at the
last position.
Characterization of defined B. pertussis and B. bronchiseptica
alcR mutants. Chromosomal deletions in alcR were con-
structed in wild-type Bordetella parental backgrounds to yield
mutations exerting little or no polarity on downstream genes.
Removal of a 264-bp NgoAIV DNA fragment internal to alcR
(Fig. 3) was predicted to result in an in-frame deletion altering
the amino-terminal region of the AlcR protein, thus avoiding
premature translation termination that may result in polar
effects on unknown downstream genes. Allelic exchange of
FIG. 2. SDS-PAGE analysis of wild-type B. bronchiseptica B013N and mu-
tant derivative BRM10. Strain B013N, streptonigrin-resistant mutant BRM10
harboring the plasmid vector pRK415, and the complementing 1.6-kb B. pertussis
KpnI-PstI DNA fragment as pP9KP were grown in parallel under iron-replete
(1) and iron-depleted (2) conditions, and cell fractions were prepared as de-
scribed in Materials and Methods. (A) Soluble cell fractions showing the iron-
repressed ca. 59-kDa AlcC protein (arrowhead). (B) Total membrane fractions;
the 79-kDa iron-repressed protein, which is absent in mutant BRM10(pRK415),
migrates as the middle species of a protein triplet (arrowhead). The migration
positions of molecular mass protein standards are shown on the left in kilodaltons.
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mutated DNA subfragments lacking 264-bp NgoAIV frag-
ments with wild-type alleles of B. pertussis UT25Sm1 and B.
bronchiseptica B013N resulted in mutants PM10 and BRM11,
respectively.
As was observed for B. bronchiseptica mutant BRM10, de-
fined B. pertussis mutant PM10 failed to produce alcaligin and
did not express AlcC (data not shown), and introduction of the
1.6-kb KpnI-PstI B. pertussis alcR DNA fragment in trans re-
stored both siderophore production (Table 1) and AlcC ex-
pression to wild-type levels. Likewise, defined B. bronchiseptica
alcR mutant BRM11 was defective in siderophore production
but was fully complemented by B. pertussis alcR (pP9KP) as
well as by the cloned wild-type B. bronchiseptica DNA region
containing alcR (data not shown). When BRM11 was supplied
in trans with a derivative of the B. bronchiseptica alcR gene in
which the internal 264-bp NgoAIV fragment was deleted, no
complementation of the siderophore production defect was
observed on CAS agar.
T7 promoter-directed expression of AlcR. AlcR production
programmed by the 1.6-kb KpnI-PstI B. pertussis DNA frag-
ment was accomplished by using a bacteriophage T7 poly-
merase-promoter protein expression system in E. coli. The
alcR open reading frame was directionally cloned positioned in
the sense orientation with respect to the bacteriophage T7
promoter in plasmid pET-3. Under inducing conditions, cells
carrying the alcR plasmid expressed a protein with a molecular
mass of approximately 34 kDa, similar to that predicted for
AlcR, which was absent in uninduced cells and host cells car-
rying the plasmid vector alone (Fig. 6). The AlcR protein was
readily visualized in electrophoretic gels as a 35S-radiolabelled
polypeptide or visualized by staining with Coomassie blue.
Involvement of AlcR in alcaligin transport and/or utiliza-
tion. The ability of B. bronchiseptica alcR mutant BRM11 to
transport and/or utilize alcaligin for growth on LB medium
made iron restricted by addition of EDDA was determined in
quantitative alcaligin growth stimulation assays using exog-
enously supplied purified alcaligin and B. bronchiseptica al-
caligin biosynthesis mutant BRM3 as a transport-proficient
positive-control indicator strain (3, 12) (Fig. 7). Growth stim-
ulation of alcR mutant BRM11 carrying the plasmid vector
control was significantly impaired at all alcaligin concentra-
tions tested, with only 30% of the growth stimulation level of
the positive-control strain achieved. B. bronchiseptica strepto-
nigrin-resistant mutant BRM10 also displayed a similar alcali-
gin utilization defect in quantitative siderophore bioassays
(data not shown). When the B. pertussis alcR gene was supplied
in trans, BRM11 alcaligin-mediated growth stimulation levels
exceeded those of the transport-proficient positive-control in-
dicator strain, perhaps attributable to multicopy effects. To-
gether, the data indicate that alcR is involved in ferric alcaligin
transport and/or utilization as well as alcaligin biosynthesis.
DISCUSSION
Treatment of a pool of B. bronchiseptica transposon mutants
with the redox-activated quinone antibiotic streptonigrin in
iron-restricted medium containing alcaligin was expected to
enrich the population for cells defective in ferric alcaligin
FIG. 3. Nucleotide sequence of alcR. The nucleotide sequence (upper strand) of the 1,200-bp region of the B. pertussis 1.6-kb KpnI-PstI DNA fragment and the
predicted amino acid sequence of AlcR in the one-letter code are shown. The transcription initiation sites (11) determined by primer extension analysis using the
designated antisense primer (arrow) are indicated. Sequences similar to the consensus Fur binding site (Fur Box) and the positions of the NgoAIV restriction
endonuclease sites used to construct deletion mutants PM10 and BRM11 are shown.
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transport or utilization functions (8, 57). B. bronchiseptica mu-
tant BRM10 exhibited a pleiotropic phenotype: it failed to
produce alcaligin, was defective in alcaligin utilization, and
lacked two iron-repressed proteins, AlcC and an iron-repress-
ible membrane protein of approximately 79 kDa. In pheno-
typic complementation analyses, the 1.6-kb KpnI-PstI DNA
subfragment of B. pertussis cosmid pCP1.11 restored alcaligin
production, as well as expression of AlcC and the 79-kDa
protein, to BRM10. However, the 1.6-kb KpnI-PstI DNA frag-
ment does not encode the AlcC protein and has insufficient
coding capacity for a 79-kDa protein. The BRM10 pleiotropic
phenotype, along with the fact that alcC expression was pre-
vented by a mutation located outside and downstream of alcC
(a phenotype that cannot be attributed to polarity on alcC),
suggested the involvement of a positive regulatory mechanism
controlling alcaligin gene expression.
While all of the Bordetella alcR mutants lacked detectable
AlcC protein, only in B. bronchiseptica (mutants BRM10 and
BRM11) could production of the 79-kDa iron-repressed mem-
brane protein be determined conclusively. The 79-kDa protein
was not readily observed in either wild-type B. pertussis cells or
B. pertussis alcR mutant PM10 due to interference from nu-
merous comigrating protein species in SDS-PAGE. Because
the alcR mutants were defective in ferric alcaligin transport
and/or utilization, it is possible that the iron-repressible 79-
kDa membrane protein may function in this capacity.
Analysis of the nucleotide sequence of the 1.6-kb KpnI-PstI
DNA fragment revealed an open reading frame, alcR, pre-
ceded by a DNA sequence with similarity to known Fur re-
pressor binding sites and which binds purified B. pertussis Fur
protein with high affinity in gel mobility shift assays (11). Two
potential AlcR translation initiation codons which would result
in an AlcR polypeptide with a molecular mass of either 36.4 or
33.9 kDa (sizes consistent with that observed for AlcR ex-
pressed in the T7 polymerase-promoter experiments) were
identified. AlcR is a new member of the AraC family of tran-
scriptional regulators, each of which exhibits the greatest sim-
ilarity at the carboxy terminus containing characteristic family
signature motifs and the helix-turn-helix region implicated in
the binding of DNA (24). AlcR showed the highest similarities
to the AraC family members PchR of P. aeruginosa (29, 30)
and YbtA of Y. pestis (21), both of which are involved in
FIG. 4. Primary amino acid sequence alignments of translated B. pertussis DNA alcR sequences with selected high-scoring AraC family members identified in
BLAST database searches. The partial sequences shown represent the highest-scoring carboxy-terminal segments of similarity. The helix-turn-helix DNA binding and
AraC signature motifs (lines), amino acid positions in the protein sequences as reported in GenBank (numbers), and residues which match the consensus (boxes) are
indicated. The GenBank accession numbers are as follows: B. pertussis AlcR, AF018255; P. aeruginosa PchR, L11657; Y. pestis YbtA, U50452; P. putida XylS, M10143,
M15819, and M20635; Y. pestis LcrF, M86690; and E. coli K-12 AraC, V00259.
FIG. 5. Localization of the iron-regulated PalcR promoter of alcR. RNA was
isolated from B. pertussis wild-type strain UT25Sm1 (WT) and B. pertussis mutant
PM-4, in which the alcA promoter-operator region is deleted, grown in iron-
replete (1Fe) and iron-depleted (2Fe) conditions. Transcriptional initiation
sites (11) corresponding to two nucleotides, C and T (at positions 124 and 125,
respectively), were mapped by primer extension analysis using the antisense
primer shown in Fig. 3.
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siderophore system gene regulation. AlcR, PchR, and YbtA
were clustered on a hypothetical phylogenetic tree generated
with the complete amino acid sequences of the AraC family
members noted in Fig. 4 and those of 16 other family members
retrieved in our database searches (data not shown).
Recent RNA hybridization experiments indicated that alcR
is transcribed as part of the Fur-controlled alcABC-containing
operon, as well as from its own iron-regulated secondary pro-
moter (32). In the present study, primer extension analysis
identified this iron-regulated promoter and the alcR transcrip-
tion initiation site. By using RNA from wild-type cells and the
alcA promoter-operator deletion mutant PM-4, further evi-
dence which is consistent with the hybridization data indicating
that alcR is also transcribed as part of a larger RNA species
(i.e., from the alcA promoter) was obtained. Although alcR
upstream sequences resembling a consensus s70 210 promoter
region were identified, there were no obvious 235 promoter
determinants. The absence of strong 235 determinants is con-
sistent with the observation that genes encoding positive reg-
ulators are usually expressed at low levels in the cell (45). In
addition, it is possible that alcR requires a positively acting
regulatory factor (perhaps AlcR itself) for optimal transcrip-
tion from PalcR.
It was determined that the transposon in the BRM10 chro-
mosome was not located in alcR and that the BRM10 alcR
gene most likely suffered a spontaneous mutation that con-
ferred streptonigrin resistance. Because of the undefined na-
ture of the BRM10 mutation, defined nonpolar chromosomal
alcR mutations in B. pertussis (PM10) and B. bronchiseptica
(BRM11) were constructed. Each mutation resulted in an in-
frame deletion of an 88-amino-acid sequence within the ami-
no-terminal region of AlcR. The amino termini of the AraC-
like regulators are presumed to be involved in substrate
recognition (24); for AraC, the amino terminus functions in
both dimerization and binding of the inducer arabinose (37).
Therefore, these Bordetella mutants may produce AlcR pro-
teins lacking the domain required for dimerization or inducer
binding. The two alcR deletion mutants exhibited phenotypes
similar to that of BRM10, consistent with defects in alcaligin
synthesis and ferric alcaligin transport. Function was restored
by supplying either the B. pertussis or the B. bronchiseptica
wild-type alcR alleles in trans.
The Fur repressor protein and its role in transcriptional
regulation of iron acquisition genes have been well docu-
mented (4, 14, 18, 26). The activities of both Fur and the more
recently described positive regulators ensure that the genes
encoding siderophore biosynthesis and transport functions are
expressed maximally only under appropriate environmental
conditions when the cognate siderophore is an effective iron
scavenger. This general type of priority regulation is an estab-
lished function of positive regulators (45). In the E. coli ferric
citrate system, the presence of ferric citrate bound to its re-
ceptor, FecA, activates transcription of the transport genes
fecABCD (35). A cytoplasmic membrane protein and the TonB
system appear to transduce the FecA receptor occupancy sig-
FIG. 6. Expression of the alcR protein product in E. coli. A T7 polymerase-
promoter system was used to express alcR from the 1.6-kb KpnI-PstI B. pertussis
DNA fragment as described in Materials and Methods. (A) Autoradiogram of
35S-labelled translational products. (B) Proteins visualized by Coomassie blue
staining. Lanes: pET-3, BL21(DE3) cells carrying the plasmid vector control;
pET-3KP, cells carrying the alcR gene. U, protein samples from uninduced cells;
I, protein samples after induction of cells by addition of IPTG. The migration
position of the 31-kDa molecular mass standard is indicated on the left. The
AlcR polypeptide is indicated on the right (arrowheads). The labelled protein in
panel A migrating at approximately 32 kDa is presumed to be the vector-encoded
b-lactamase.
FIG. 7. Alcaligin utilization bioassays. Promotion of growth of B. bronchi-
septica by exogenously supplied alcaligin in iron-restricted medium was per-
formed as detailed in Materials and Methods. Alcaligin biosynthesis mutant
BRM3 is wild type with respect to ferric alcaligin transport. The diameters of the
zones of growth include the 6 mm contributed by the sample well. Bacteria
supplied with diluent alone showed no growth stimulation. Standard deviations
are indicated as vertical bars; no standard deviation bars are shown if the values
were less than 0.4.
TABLE 1. Alcaligin siderophore activity of B. pertussis
Strain
Siderophore activitya
With iron Without iron
UT25Sm1 (wild type) 0.018 6 0.014 0.592 6 0.014
PM10/pP9KP (alcR1) 0.000 6 0.028 0.747 6 0.006
PM10/pRK415 (vector) 0.000 6 0.026 0.047 6 0.005
a Mean relative CAS siderophore activities [calculated as 1 2 (Asample/
Areference), n 5 3] of cultures of wild-type strain UT25Sm1 and alcR mutant
PM10 carrying the indicated plasmids grown in iron-replete and iron-depleted
media 6 standard deviations. The reference value (Areference) was the absor-
bance value at 630 nm obtained with uninoculated medium.
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nal to the regulator FecI, a cytoplasmic protein bearing signif-
icant similarity to alternative sigma factors. Other siderophore
systems positively regulated through the function of alternative
sigma factor-like proteins include the Pseudomonas putida
WCS358 native and heterologous pseudobactin systems (55) as
well as the native pyoverdin system of P. aeruginosa (15). A
second type of positive regulation of siderophore utilization
genes has been described only for the PfeR-PfeS system of
P. aeruginosa, which allows the organism to respond to the
heterologous siderophore enterobactin, resulting in up-regu-
lated expression of the ferric enterobactin receptor PfeA (16).
PfeR and PfeS are similar to proteins of classical two-compo-
nent sensory transduction systems. The third type of positive
regulation of siderophore gene expression involves proteins
which are members of the AraC family of transcriptional reg-
ulators, some of which can act positively or negatively, depend-
ing on the presence or absence of inducer and the position of
the regulator binding site on the DNA (24, 45). These AraC-
like regulators include the P. aeruginosa PchR and Y. pestis
YbtA proteins and now Bordetella AlcR. Pyochelin biosynthe-
sis and transport are regulated in P. aeruginosa both positively
and negatively by PchR; the system responds to pyochelin and
requires the pyochelin receptor (29, 30). In Y. pestis, YbtA acts
both positively and negatively in the regulation of the yersini-
abactin receptor (21). The specific mechanisms of action of
these AraC-like regulators of siderophore genes are undefined
at present but may involve direct activation by the cognate
siderophore (or a degradation product thereof) functioning as
an inducer. The alcR mutant phenotype, together with the
similarities between AlcR, PchR, YbtA, and other members of
the AraC protein family, indicates that alcaligin biosynthesis
and transport genes in Bordetella spp. can not only be re-
pressed by Fur but also can be controlled by the AlcR regulator
protein.
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